Mean Residence Time After Transhepatic Infusion of 111In-DTPA-d-Phe1-Octreotide
| Mean residence time (h) ± SD | |||||
|---|---|---|---|---|---|
| Patient no. | Liver | Kidney | Spleen | Tumor | Remainder |
| 1 | 2.9 ± 0.8 | 2.7 ± 0.6 | 5.7 ± 1.3 | 7.5 ± 1.5 | 5.2 ± 2.2 |
| 2 | 2.5 ± 0.6 | 2.0 ± 0.8 | 5.3 ± 1.4 | 9.4 ± 4.2 | 11.0 ± 5.9 |
| 3 | 7.6 ± 1.9 | 4.1 ± 1.1 | 6.7 ± 2.2 | 10.2 ± 5.8 | 6.2 ± 3.5 |
| 4 | 2.1 ± 0.6 | 2.3 ± 0.4 | 2.6 ± 0.4 | 6.2 ± 1.9 | 9.1 ± 4.9 |
| 5 | 3.6 ± 0.4 | 3.4 ± 0.3 | 6.5 ± 0.6 | 24.3 ± 7.7 | 11.5 ± 2.5 |
| 6 | 2.6 ± 0.2 | 3.5 ± 0.8 | 1.2 ± 0.5 | NA | 13.1 ± 6.9 |
| 7 | 3.8 ± 1.4 | 4.2 ± 0.7 | 5.2 ± 1.2 | 6.7 ± 1.4 | 5.0 ± 0.6 |
| 8 | 4.5 ± 0.6 | 4.4 ± 0.1 | 5.1 ± 1.5 | 6.1 ± 3.3 | 10.2 ± 0.6 |
| 9 | 4.0 ± 1.1 | 3.7 ± 0.6 | 6.3 ± 1.0 | NA | 8.4 ± 2.4 |
| 10 | 3.1 ± 0.8 | 5.9 ± 0.1 | NA | 17.7 ± 1.9 | 7.1 ± 3.4 |
| 11 | 1.8 ± 0.4 | 5.3 ± 0.8 | 2.0 ± 0.3 | 1.3 ± 0.2 | 5.4 ± 0.9 |
| 12 | 4.4 ± 1.0 | 4.4 ± 1.3 | 5.4 ± 1.3 | 10.6 ± 2.6 | 9.2 ± 0.3 |
| Mean ± SD | 3.2 ± 0.9 | 3.5 ± 0.9 | 4.7 ± 1.9 | 11.0 ± 7.2 | 8.4 ± 2.7 |
NA = not applicable.